Showing results (221-230 of 308) with videos related to

Sort By:
Pageof 31
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 22, 2018
Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret modelDaniil A Korenkov, Karen L Laurie, Patrick C Reading, et al.
The Journal of Clinical Investigation|April 15, 2010
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccineDavide Corti, Amorsolo L Suguitan, Debora Pinna, et al.
The Journal of Infectious Diseases|April 4, 2015
High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza VaccineJessica L Halliley, Surender Khurana, Florian Krammer, et al.
Open Forum Infectious Diseases|July 16, 2016
Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza VaccinePeter F Wright, Anne G Hoen, Natalia A Ilyushina, et al.
Communications Medicine|May 1, 2026
Influenza vaccine responses differ between young children previously exposed to influenza antigens via infection versus vaccinationAnnette Fox, Annette Alafaci, Louise Carolan, et al.
Clinical and Vaccine Immunology : CVI|April 12, 2013
B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccinationMark Y Sangster, Jane Baer, Felix W Santiago, et al.
Journal of Virology|August 27, 2025
Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strainsMatthew J Gartner, Monique L Smith, Clyde Dapat, et al.
Microorganisms|August 26, 2023
Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19Marilou H Barrios, Suellen Nicholson, Rowena A Bull, et al.
Antiviral Research|February 1, 2020
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018Emi Takashita, Rod S Daniels, Seiichiro Fujisaki, et al.
The Journal of Infectious Diseases|January 19, 2005
Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in miceThomas C Greenough, Gregory J Babcock, Anjeanette Roberts, et al.
Pageof 31